FDA Approves Durvalumab for Muscle Invasive Bladder Cancer By Ogkologos - May 2, 2025 856 0 Facebook Twitter Google+ Pinterest WhatsApp Evidence for efficacy is based on the results from the NIAGARA study Source RELATED ARTICLESMORE FROM AUTHOR Comprehensive Genomic Profiling with Subsequent Molecularly Guided Therapy Improves Outcomes Over Platinum-based Chemotherapy in Previously Untreated, Unfavourable CUP NCI and CRUK Take on Cancer’s Toughest Problems Tebentafusp Continues to Provide Long-Term OS Benefit in Previously Untreated Patients with Unresectable or Metastatic Uveal Melanoma MOST POPULAR Dealing With Fears March 24, 2021 Time to get stratified January 10, 2023 Color-Blind Groom Sees Color For First Time After Bride Surprises Him... November 9, 2021 Study Clarifies Timing of Immunotherapy for Advanced Bladder Cancer June 24, 2020 Load more HOT NEWS Mothers Raise Girls Together After Discovering They Were Swapped At Birth Teclistamab Significantly Improves Survival Among Patients with Multiple Myeloma Who Previously... Researchers Have Harnessed a Compound from a Common Plant Called Feverfew... Cemiplimab Outperforms Investigator’s Choice Chemotherapy in the Second-Line Setting for Recurrent/Metastatic...
